Toth Financial Advisory’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Toth Financial Advisory’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.33M	Hold	20,725	–	–	0.13%	128
2026 Q1	$998K	Sell	20,725 -840	-4%	-$37.2K	0.11%	131
2025 Q4	$890K	Hold	21,565	–	–	0.1%	143
2025 Q3	$837K	Buy	21,565 +10,865	+102%	+$353K	0.09%	144
2025 Q2	$296K	Buy	+10,700	New	+$272K	0.03%	194

Other funds holding KNSA

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

LTAS

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

FEG

Financial Enhancement Group Anderson, Indiana $839M AUM 18.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

JWS

Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Toth Financial Advisory's KNSA Position: Q2 2026 in Review

Toth Financial Advisory held its Kiniksa Pharmaceuticals (KNSA) position steady in Q2 2026 at 20,725 shares worth $1.33M. The position accounts for 0.13% of the portfolio, ranked #128.

Toth Financial Advisory first reported a position in KNSA in Q2 2025 and has held it in 5 quarters since. 16 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

Toth Financial Advisory held 20,725 shares of Kiniksa Pharmaceuticals worth $1.33M as of Q2 2026.
Toth Financial Advisory left its Kiniksa Pharmaceuticals share count unchanged in Q2 2026.
Kiniksa Pharmaceuticals made up 0.13% of Toth Financial Advisory's portfolio in Q2 2026, its #128 holding.
Toth Financial Advisory first reported a position in Kiniksa Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
16 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.